GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 92 filers reported holding GALENA BIOPHARMA INC in Q2 2014. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $49,000 | -7.5% | 141,000 | +24.2% | 0.00% | -33.3% |
| Q2 2016 | $53,000 | -98.9% | 113,530 | -96.7% | 0.00% | -98.5% |
| Q1 2015 | $4,777,000 | +2142.7% | 3,436,456 | +2338.2% | 0.20% | +2742.9% |
| Q4 2014 | $213,000 | -63.4% | 140,944 | -50.1% | 0.01% | -68.2% |
| Q3 2014 | $582,000 | -28.3% | 282,704 | +6.5% | 0.02% | -37.1% |
| Q2 2014 | $812,000 | -54.1% | 265,350 | -62.5% | 0.04% | -64.6% |
| Q1 2014 | $1,770,000 | – | 708,089 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spark Investment Management LLC | 308,500 | $462,000 | 0.08% |
| Perceptive Advisors | 200,000 | $302,000 | 0.02% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 29,675 | $45,000 | 0.02% |
| EXANE DERIVATIVES | 100,000 | $150,995,000 | 0.02% |
| PIPER SANDLER & CO. | 20,000 | $30,000 | 0.02% |
| Alyeska Investment Group, L.P. | 530,000 | $801,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 15,000 | $23,000 | 0.01% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 13,350 | $20,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 458,952 | $693,000 | 0.01% |
| WOLVERINE ASSET MANAGEMENT LLC | 1,605 | $388,000 | 0.01% |